| Product NDC: | 66993-175 |
| Proprietary Name: | Dorzolamide Hydrochloride |
| Non Proprietary Name: | dorzolamide hydrochloride |
| Active Ingredient(s): | 20 mg/mL & nbsp; dorzolamide hydrochloride |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 66993-175 |
| Labeler Name: | Prasco Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020408 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19941209 |
| Package NDC: | 66993-175-20 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (66993-175-20) > 10 mL in 1 BOTTLE, DROPPER |
| NDC Code | 66993-175-20 |
| Proprietary Name | Dorzolamide Hydrochloride |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (66993-175-20) > 10 mL in 1 BOTTLE, DROPPER |
| Product NDC | 66993-175 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dorzolamide hydrochloride |
| Dosage Form Name | SOLUTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19941209 |
| Marketing Category Name | NDA |
| Labeler Name | Prasco Laboratories |
| Substance Name | DORZOLAMIDE HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] |